Edesa Biotech Current Cash

Edesa Biotech (EDSA) currently reports a current cash of $10M as of March 2026. That compares with $14M in the prior-year period — down 28.0% year over year. Use the charts on this page to explore Edesa Biotech's current cash history and peer comparisons.

Edesa Biotech's current cash decreased from $14M to $10M — a 28.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Edesa Biotech reported $10M in current cash as of March 2026. That compares with $14M in the prior-year period — down 28.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Edesa Biotech, and consider following EDSA for alerts when major investors trade the stock.

Edesa Biotech is classified in the Healthcare sector. On current cash, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EDSA with unrelated industries.